2.50
price down icon3.10%   -0.08
after-market Dopo l'orario di chiusura: 2.55 0.05 +2.00%
loading
Precedente Chiudi:
$2.58
Aprire:
$2.49
Volume 24 ore:
14,181
Relative Volume:
0.01
Capitalizzazione di mercato:
$6.29M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.1682
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
-2.72%
1M Prestazione:
-4.94%
6M Prestazione:
+2.88%
1 anno Prestazione:
-26.25%
Intervallo 1D:
Value
$2.40
$2.6134
Intervallo di 1 settimana:
Value
$2.40
$2.68
Portata 52W:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Nome
Cyclerion Therapeutics Inc
Name
Telefono
617-621-7722
Name
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Name
Dipendente
1
Name
Cinguettio
@Cyclerion
Name
Prossima data di guadagno
2024-12-15
Name
Ultimi documenti SEC
Name
CYCN's Discussions on Twitter

Confronta CYCN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.50 6.29M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-10-20 Iniziato Truist Buy
2021-09-24 Iniziato Cantor Fitzgerald Overweight
2019-06-03 Iniziato Credit Suisse Neutral

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025
pulisher
Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025
pulisher
Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025
pulisher
Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 08, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 3.5% – Time to Buy? - Defense World

Jan 08, 2025
pulisher
Jan 03, 2025

Looking Into Cyclerion Therapeutics's Recent Short Interest - Benzinga

Jan 03, 2025
pulisher
Dec 23, 2024

Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress - Stocks Telegraph

Dec 23, 2024
pulisher
Dec 19, 2024

Cyclerion Therapeutics (NASDAQ: CYCN) Amends License Agreement with Akebia Therapeutics and Generates Revenues for GrowthOn December 17, 2024, Cyclerion Therapeutics, Inc. filed an 8-K SEC Filing which detailed significant developments in its b - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion Therapeutics Secures Funding and Expands CNS Focus - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements By Investing.com - Investing.com UK

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewswire

Dec 17, 2024

Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):